This study was devoted to the learning of the use of nanotechnology to correct the functional activity of red blood cells (RBCs) at the storage stages at a positive temperature. It was established that saline NaCl, which had previously been processed by magnetite nanoparticles (ICNB) had a marked membrane-stabilizing effect, inhibits hemolysis and increasing the sedimentation stability of preserved RBCs. The complex analysis of the obtained data allowed to determine the primary mechanisms effect of the saline NaCl, which had previously been processed by ICNB on the preserved RBCs. The proposed method of additive modernization of preserved RBCs was adapted to the production process. The optimization results were obtained in creating a simple and practical method of additive modernization of preservation solutions that does not violate the compliance requirements, improves the quality, efficiency and safety transfusion of RBCs.
life-saving treatment for severe anemia caused by disease or chemotherapy, or by blood loss due to trauma or major surgery. For several decades RBCs components have been prepared as concentrates suspended in nutrient additive solution, which preserves and extends the shelf-life of the RBCs component, allowing up to 6-7 weeks of refrigerated storage [1] .
Nevertheless, during storage RBCs undergo a complex and progressive accumulation of physicochemical changes, collectively referred to as the RBCs storage lesion [2, 3] . Recent clinical studies have identified RBCs transfusion as an independent risk factor for increased morbidities and mortalities in certain groups of patients, including trauma, cardiac surgery and the critically-ill (reviewed in [4 -6] ). Additionally, some of these studies have identified that older stored RBCs are more strongly implicated in poorer outcomes compared to fresher RBCs [6] . In order to address these concerns, there is renewed interest to better understand the RBCs storage lesion and to find ways to ameliorate the deleterious effects of storage, thereby improving the quality, efficacy and safety of RBCs components for all transfusion recipients.
While increased research effort is being directed to better understand the effects of storage on RBCs and the potential impact on transfusion outcomes [7] , slower progress is being made in finding ways to deter the detrimental effects of the RBCs storage lesion.
Over the past 15 -20 years, research into the development of new additive solutions has focused on ways to maintain higher intracellular levels of ATP and 2.3-DPG during storage of RBC components [1] . and sick patients [17] [18] [19] . Previously the complex investigations that were performed in the study of the 
Materials and Methods
Materials: • Concentration of the colloidal solution of magnetite nanoparticles in physiology solution of NaCl is 0.0225%.
• Theoretical osmolality of colloid solution is 500 mosmol/l
• Size of magnetite nanoparticles is 6-12 nm;
• Total area of surface magnetite of nanoparticles Ss = 800-1200 m 2 /g;
• Magnetization of saturation Is = 2.15 кА/m;
• ζ -potential = -19 mV 2. 0.9% NaCl solution. The axial tomograms were received
• T1 -the self-weighted sequences of Echo Spin of TR 50 ms, TE 17 ms the field of review the 250 mm, the thickness cut 2 mm.
• T2 -the self-weighted sequences Echo Gradient of TR 500 ms, TE 17 ms the field of review a 180 mm, the thickness cut 4 mm.
Of each bag of 3 ml amounts of red blood cells was distributed into 20 sterile glass tubes. Then, into the first 10 tubes of control were added of 2 ml amounts 0.9% NaCl solution. Into the next 10 tubes of test were added of 2 ml amounts 0.9% NaCl solution, which previously was processed by ICNB.
Thus, the distribution of tubes was as the follows:
Tubes of control • 3 ml of red blood cells (CPD) +2 ml 0.9% NaCl solution (n=10);
• 3 ml of red blood cells (CPDA-1) +2 ml 0.9% NaCl solution (n=10).
Tubes of test
• 3 ml of red blood cells (CPD) +2 ml 0.9% NaCl solution that previously was processed by ICNB in ratio 4:1 (n=10);
• 3 ml of red blood cells (CPDA-1) +2 ml 0.9% NaCl solution that previously was processed by ICNB in ratio 4:1 (n=10).
The state of red blood cells was determined visually by the registration of signs of hemolysis. Also, hemolysis was controlled by photometric method by means Plasma / Low Hb and GPHP-01 devices. The centrifuge mark of SM-70M-07 was used to obtain supernatant. Hematocrit was calculated by means hematocrit ruler and using the formula:
Morphology of the red blood cells was studied by direct microscopic method. Sedimentation stability of red blood cells was studied by Panchenkov's method.
Change in the acidity of the red blood cells was performed by means of pH metric.
Tests were carried out in six stages: day 1 -I, day 7 -II, day 14 -III, day 21 -IV, day 28 -V, day
-VI.
The blood after performance of the biochemical investigation was stored in the refrigerating chamber at temperature +4ºС.
Statistically processing the obtained results was carried out by parametrical method of variation statistics by Student criterion. Processing the obtained data was carried out by means of Excel.
Results and Discussion
Results of visual assessment of the images brightness used in experiment liquids at the MRI are represented in Figure 3 . • Variant 2. Rising mobility of hydrogen protons in the intact 0.9% NaCl solution increased brightness in comparison with Variant 1.
• Variant 3. Mobility of hydrogen protons in 0.9% NaCl solution that has previously been processed ICNB nanoparticles is maximized. Therefore, the image brightness is much higher than before (in the previous variants). Objective data of free Hb and calculated HCT at the stage VI of the study are presented in Table 5 .
Thus, the objective indicators of Table 5 shape changes of human erythrocytes [36] .
The effect of hemolysis inhibition by the method of additive modernization of preservation solutions, that adapted to the manufacture process at the VI stage of the study is shown in Figure 10 .
Conclusion
As a result of the studies it was found that physiologic solution NaCl which previously was 
